Cell-active small molecule inhibitors validate the SNM1A DNA repair nuclease as a cancer target by Bielinski, M, Henderson, LR, Yosaatmadja, Y, Swift, LP, Baddock, HT, Bowen, MJ, Brem, J, Jones, PS, McElroy, SP, Morrison, A, Speake, M, van Boeckel, S, van Doornmalen, E, van Groningen, J, van den Hurk, H, Gileadi, O, Newman, JA, McHugh, PJ, Schofield, CJ

Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors by Brem, J, Panduwawala, T, Hansen, JU, Hewitt, J, Liepins, E, Donets, P, Espina, L, Farley, AJM, Shubin, K, Campillos, GG, Kiuru, P, Shishodia, S, Krahn, D, Leśniak, RK, Schmidt Adrian, J, Calvopiña, K, Turrientes, M-C, Kavanagh, ME, Lubriks, D, Hinchliffe, P, Langley, GW, Aboklaish, AF, Eneroth, A, Backlund, M, Baran, AG, Nielsen, EI, Speake, M, Kuka, J, Robinson, J, Grinberga, S, Robinson, L, McDonough, MA, Rydzik, AM, Leissing, TM, Jimenez-Castellanos, JC, Avison, MB, Da Silva Pinto, S, Pannifer, AD, Martjuga, M, Widlake, E, Priede, M, Hopkins Navratilova, I, Gniadkowski, M, Belfrage, AK, Brandt, P, Yli-Kauhaluoma, J, Bacque, E, Page, MGP, Björkling, F, Tyrrell, JM, Spencer, J, Lang, PA, Baranczewski, P, Cantón, R, McElroy, SP, Jones, PS, Baquero, F, Suna , E, Morrison, A, Walsh, TR, Schofield, CJ